5 days ago
TEVA
AnalystsAshwani VermaAshwani Verma's Stock Forecasts
AnalystsAshwani Verma
Analyst Ranking
Top 12%
#593 out of 5267 analysts
Average Return
+13.69%
Win Rate
58%52 out of 90
Risk vs Reward
Poor
Good
Ashwani Verma's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arcellx IncACLX | +164.51% | $35.16 | $93.00 | 2023-10-16 - 2024-10-16 | Strong Buy |
Avadel Pharmaceuticals PLCAVDL | +137.72% | $7.82 | $18.59 | 2025-01-12 - 2025-10-28 | Strong Buy |
Cytokinetics IncCYTK | +116.84% | $37.71 | $81.77 | 2023-04-02 - 2024-01-24 | Strong Buy |
Axsome Therapeutics IncAXSM | +116.64% | $103.26 | $223.70 | 2025-08-05 - 2026-05-04 | Strong Buy |
Teva Pharmaceutical Industries LtdTEVA | +113.47% | $16.56 | $35.35 | 2025-06-25 - 2026-05-04 | Strong Buy |
Ashwani Verma Analyst Color
Get additional color on Ashwani Verma's coverage of popular stocks
14 days ago
RPRX
25 days ago
AXSM
4 months ago
AXSM
5 months ago
JAZZ
6 months ago
ABBV
7 months ago
NBIX
7 months ago
TEVA
2 years ago
TEVA
2 years ago
LEGN
2 years ago
ITCI
Ashwani Verma's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Teva Pharmaceutical Industries LtdTEVA | 11 | Strong Buy | $42.00 | +18.81% | Maintains | 5 days ago |
Royalty Pharma PLCRPRX | 5 | Strong Buy | $57.00 | +13.55% | Maintains | 14 days ago |
Amneal Pharmaceuticals IncAMRX | 1 | Strong Buy | $19.00 | +44.93% | Initiates Coverage On | 18 days ago |
Axsome Therapeutics IncAXSM | 8 | Strong Buy | $259.00 | +15.78% | Maintains | 25 days ago |
Incyte CorpINCY | 3 | Hold | $94.00 | -3.23% | Maintains | a month ago |
AlvotechALVO | 2 | Strong Buy | $6.00 | +70.45% | Maintains | a month ago |
Cytokinetics IncCYTK | 6 | Hold | $69.00 | +4.47% | Maintains | 2 months ago |
United Therapeutics CorpUTHR | 12 | Strong Buy | $705.00 | +21.30% | Maintains | 2 months ago |
Harmony Biosciences Holdings IncHRMY | 4 | Hold | $46.00 | +41.15% | Downgrades | 3 months ago |
Neurocrine Biosciences IncNBIX | 11 | Strong Buy | $178.00 | +32.77% | Maintains | 3 months ago |
Insmed IncINSM | 1 | Strong Buy | $215.00 | +53.56% | Maintains | 4 months ago |
Acadia Pharmaceuticals IncACAD | 9 | Strong Buy | $40.00 | +80.26% | Maintains | 4 months ago |
Corcept Therapeutics IncCORT | 1 | Hold | $95.00 | +84.11% | Initiates Coverage On | 5 months ago |
Legend Biotech CorpLEGN | 4 | Strong Buy | $48.00 | +81.13% | Maintains | 5 months ago |
Biohaven LtdBHVN | 5 | Hold | $11.00 | +8.48% | Downgrades | 5 months ago |
Jazz Pharmaceuticals PLCJAZZ | 7 | Hold | $188.00 | -9.64% | Downgrades | 5 months ago |
Abbvie IncABBV | 1 | Hold | $220.00 | +5.69% | Maintains | 6 months ago |
Exelixis IncEXEL | 5 | Hold | $40.00 | -9.44% | Maintains | 6 months ago |
Avadel Pharmaceuticals PLCAVDL | 4 | Hold | $20.00 | -7.58% | Downgrades | 6 months ago |
Immunovant IncIMVT | 1 | Hold | $18.00 | -35.37% | Maintains | 9 months ago |
Alkermes PLCALKS | 4 | Strong Buy | $42.00 | +22.91% | Upgrades | a year ago |
Coherus Oncology IncCHRS | 5 | Hold | $1.05 | N/A | Maintains | a year ago |
Arcellx IncACLX | 2 | Strong Buy | $114.00 | N/A | Maintains | a year ago |
Intra Cellular Therapies IncITCI | 5 | Hold | $79.00 | N/A | Maintains | 2 years ago |
Coherent CorpCOHR | 1 | Strong Buy | $7.00 | N/A | Maintains | 3 years ago |
Karuna Therapeutics IncKRTX | 2 | Hold | $209.00 | N/A | Initiates Coverage On | 3 years ago |
Viatris IncVTRS | 2 | Hold | $12.00 | N/A | Upgrades | 3 years ago |
Rani Therapeutics Holdings IncRANI | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 4 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 3 | Hold | $71.00 | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.